Dr Harriette Van Spall (McMaster University, Ontario, CA) & Prof John McMurray (Glasgow University Hospital, UK) discuss the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) - Sub-studies and sensitivity anaylses.
Filmed on site at AHA 2019 by Radcliffe Cardiology.
Videographer: Tom Green & Dominic Woodruff
See more videos here :
RC Academy :
radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions.